Therapy is the first oral MET inhibitor treatment option for certain advanced NSCLC adult patients
News
Stada and Xbrane receive approval for Ximluci
Biosimilar gains MHRA marketing authorisation for use throughout Britain
Medicines Discovery Catapult and SMi gain cancer biomarker funding
Industry-first cancer screening technology boosted by biomedical grant funding
Celadon receives good manufacturing practice approval
MHRA approval relates to the company’s midlands-based drug development facilities
AbbVie and Eli Lilly snub drug pricing agreement
Major industry names depart leaving UK pricing deal in serious jeopardy
AstraZeneca’s Tezspire receives approval for asthma treatment
Green light for new asthma pen which offers self-administration option across the EU
Moderna becomes latest company to join the ABPI
Company becomes the latest member of the ABPI and galvanises the company’s UK connections
Carbios and Novozymes form biorecycling strategic partnership
Collaboration involves the development, optimisation and production of proprietary enzymes
CRO EastHORN picked up by Novotech
Agreement ensures that clients can access Novotech’s early to late-phase CRO services across Europe
AlzeCure begins Alzheimer’s therapy development phase
Candidate will go through the development programme, which includes safety and tolerability studies
Pheno and UCB reveal neurodegenerative disease programme agreement
Global preclinical programme has the potential for disease modifying therapeutics
Artificial pancreas technology set to change lives
Emerging technology could help patients who are unable to manage their type 1 diabetes
SIFI and Avanzanite announce AKANTIOR agreement
Partnership offers treatment access to hundreds of patients across several European countries
NHS Confederation responds to Prime Minister’s promise of NHS support
New financial assistance emerges as UK Government announces imminent discharge fund
AstraZeneca makes CinCor Pharma acquisition
Agreement involves access to global rights of blood pressure lowering therapy baxdrostat
